对于早期喉癌治疗的VMAT输送角度的剂量影响

Masao Nakayama1, Shuhei Sekii2, Eiichi Miyazaki3

  • 1Division of Radiation Therapy, Kita-Harima Medical Center, Ono, Hyogo 675-1392, Japan; Division of Radiation Oncology, Kobe University Graduate School of Medicine, Kobe City, Hyogo 650-0017, Japan; Discipline of Medical Radiations, School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria 3083, Australia.

概括

对于早期的喉腔癌,体积调制弧线疗法 (VMAT) 中的部分弧形门架角度可以增加计划目标体积 (PTV) 剂量,同时节省有风险的器官 (OAR). 然而,这些计划显示了更大的OAR剂量变化与定位错误.